
Oncodetect Test Is Now Available for MRD Detection in Solid Tumors
The Oncodetect test is now available for use in molecular residual disease (MRD) detection in patients with solid tumors.1 Oncodetect is a highly sensitive, tumor-informed test designed to detect up to 200 circulating tumor DNA (ctDNA) variants. The test …